Role of Cardiac Myocyte CXCR4 Expression in Development and Left Ventricular Remodeling After Acute Myocardial Infarction

被引:62
作者
Agarwal, Udit [1 ,2 ,3 ]
Ghalayini, Wael [1 ,2 ,3 ]
Dong, Feng [1 ,2 ,3 ]
Weber, Kristal [1 ,2 ,3 ]
Zou, Yong-Rui [7 ]
Rabbany, Sina Y. [5 ,8 ]
Rafii, Shahin [5 ,6 ]
Penn, Marc S. [1 ,2 ,3 ,4 ]
机构
[1] Cleveland Clin, Dept Cardiovasc Med, Skirball Lab Cardiovasc Cellular Therapeut, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Stem Cell Biol, Skirball Lab Cardiovasc Cellular Therapeut, Cleveland, OH 44195 USA
[3] Cleveland Clin, Dept Regenerat Med, Skirball Lab Cardiovasc Cellular Therapeut, Cleveland, OH 44195 USA
[4] Cleveland Clin, Inst Heart & Vasc, Ctr Cardiovasc Cell Therapy, Cleveland, OH 44195 USA
[5] Cornell Univ, Weill Med Coll, Dept Med Genet, New York, NY 10021 USA
[6] Cornell Univ, Weill Med Coll, Howard Hughes Med Inst, New York, NY 10021 USA
[7] Long Isl Jewish Med Ctr, Feinstein Lab Hematopoiesis, New York, NY USA
[8] Hofstra Univ, Bioengn Program, Hempstead, NY 11550 USA
关键词
stem cells; myocardial infarction; cardiogenesis; CHEMOKINE RECEPTOR CXCR4; CELL RECRUITMENT; PROGENITOR CELLS; MICE DEFICIENT; SDF-1; MYELOPEROXIDASE; TRANSPLANTATION; CARDIOMYOPATHY; HEMATOPOIESIS; REGENERATION;
D O I
10.1161/CIRCRESAHA.110.223289
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Stromal cell-derived factor (SDF)-1/CXCR4 axis has an instrumental role during cardiac development and has been shown to be a potential therapeutic target for optimizing ventricular remodeling after acute myocardial infarction (AMI) and in ischemic cardiomyopathy. Although a therapeutic target, the specific role of cardiac myocyte CXCR4 (CM-CXCR4) expression following cardiogenesis and survival of cardiac myocyte and left ventricular remodeling after AMI is unknown. Objective: We hypothesized that cardiac myocyte derived CXCR4 is critical for cardiac development, but it may have no role in adulthood secondary to the short transient expression of SDF-1 and the delayed expression of CM-CXCR4 following AMI. To address this issue, we developed congenital and conditional CM-CXCR4(-/-) mouse models. Methods and Results: Two strains of CM-CXCR4(flox/flox) mice were generated by crossing CXCR4(flox/flox) mice with MCM-Cre(+/-) mouse and MLC2v-Cre(+/-) mouse on the C57BL/6J background, yielding CXCR4(flox/flox) MCM-Cre(+/-) and CXCR4(flox/flox)MLC2v-Cre(+/-) mice. Studies demonstrated recombination in both models congenitally in the MLC2v-Cre(+/-) mice and following tamoxifen administration in the MCM-Cre(+/-) mice. Surprisingly the CXCR4(flox/flox)MLC2v-Cre(+/-) are viable, had normal cardiac function, and had no evidence of ventricular septal defect. CXCR4(flox/flox)MCM(+/-) treated with tamoxifen 2 weeks before AMI demonstrated 90% decrease in cardiac CXCR4 expression 48 hours after AMI. Twenty-one days post AMI, echocardiography revealed no statistically significant difference in the wall thickness, left ventricular dimensions or ejection fraction (40.9 +/- 7.5 versus 34.4 +/- 2.6%) in CXCR4(flox/flox) mice versus CM-CXCR4(-/-) mice regardless of strategy of Cre expression. No differences in vascular density (2369 +/- 131 versus 2471 +/- 126 vessels/mm(2); CXCR4(flox/flox) versus CM-CXCR4(-/-) mouse), infarct size, collagen content, or noninfarct zone cardiac myocyte size were observed 21 days after AMI. Conclusions: We conclude that cardiac myocyte-derived CXCR4 is not essential for cardiac development and, potentially because of the mismatch in timings of peaks of SDF-1 and CXCR4, has no major role in ventricular remodeling after AMI. (Circ Res. 2010;107:667-676.)
引用
收藏
页码:667 / U236
页数:13
相关论文
共 40 条
[1]   Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction [J].
Askari, AT ;
Brennan, ML ;
Zhou, XR ;
Drinko, J ;
Morehead, A ;
Thomas, JD ;
Topol, EJ ;
Hazen, SL ;
Penn, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (05) :615-624
[2]   Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy [J].
Askari, AT ;
Unzek, S ;
Popovic, ZB ;
Goldman, CK ;
Forudi, F ;
Kiedrowski, M ;
Rovner, A ;
Ellis, SG ;
Thomas, JD ;
DiCorleto, PE ;
Topol, EJ ;
Penn, MS .
LANCET, 2003, 362 (9385) :697-703
[3]   Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction -: (TOPCARE-AMI) [J].
Assmus, B ;
Schächinger, V ;
Teupe, C ;
Britten, M ;
Lehmann, R ;
Döbert, N ;
Grünwald, F ;
Aicher, A ;
Urbich, C ;
Martin, H ;
Hoelzer, D ;
Dimmeler, S ;
Zeiher, AM .
CIRCULATION, 2002, 106 (24) :3009-3017
[4]   Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI) -: Mechanistic insights from serial contrast-enhanced magnetic resonance imaging [J].
Britten, MB ;
Abolmaali, ND ;
Assmus, B ;
Lehmann, R ;
Honold, J ;
Schmitt, J ;
Vogl, TJ ;
Martin, H ;
Schächinger, V ;
Dimmeler, S ;
Zeiher, AM .
CIRCULATION, 2003, 108 (18) :2212-2218
[5]   Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis [J].
Brunner, Stefan ;
Winogradow, Janina ;
Huber, Bruno C. ;
Zaruba, Marc-Michael ;
Fischer, Rebekka ;
David, Robert ;
Assmann, Gerald ;
Herbach, Nadja ;
Wanke, Ruediger ;
Mueller-Hoecker, Josef ;
Franz, Wolfgang-Michael .
FASEB JOURNAL, 2009, 23 (02) :351-361
[6]   Effects of CXCR4 Gene Transfer on Cardiac Function After Ischemia-Reperfusion Injury [J].
Chen, Jiqiu ;
Chemaly, Elie ;
Liang, Lifan ;
Kho, Changwon ;
Lee, Ahyoung ;
Park, Jaeho ;
Altman, Perry ;
Schecter, Alison D. ;
Hajjar, Roger J. ;
Tarzami, Sima T. .
AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (04) :1705-1715
[7]  
Czarnowska E, 2007, J PHYSIOL PHARMACOL, V58, P729
[8]   Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure [J].
Damås, JK ;
Eiken, HG ;
Oie, E ;
Bjerkeli, V ;
Yndestad, A ;
Ueland, T ;
Tonnessen, T ;
Geiran, OR ;
Aass, H ;
Simonsen, S ;
Christensen, G ;
Froland, SS ;
Attramadal, H ;
Gullestad, L ;
Aukrust, P .
CARDIOVASCULAR RESEARCH, 2000, 47 (04) :778-787
[9]   Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis [J].
Darash-Yahana, M ;
Pikarsky, E ;
Abramovitch, R ;
Zeira, E ;
Pal, B ;
Karplus, R ;
Beider, K ;
Avniel, S ;
Kasem, S ;
Galun, E ;
Peled, A .
FASEB JOURNAL, 2004, 18 (09) :1240-+
[10]   SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells [J].
De Falco, E ;
Porcelli, D ;
Torella, AR ;
Straino, S ;
Iachininoto, MG ;
Orlandi, A ;
Truffa, S ;
Biglioli, P ;
Napolitano, M ;
Capogrossi, MC ;
Pesce, M .
BLOOD, 2004, 104 (12) :3472-3482